Abstract:Parkinson's disease (PD) is a common degenerative disease of the central nervous system among the elderly. Istradefylline, an FDA-approved adenosine A(2A) receptor antagonist (anti-PD drug), has good efficacy. However, it has been reported that the double bond of istradefylline is easily converted into cis-configuration when exposed to an indoor environment or direct light in a dilute solution. In order to find more stable adenosine A(2A) receptor antagonists with similar pharmacological efficacy to istradefylline, the compounds series I-1 (12 compounds) was designed by maintaining the xanthine skeleton of istradefylline unchanged and replacing the trans-double bond with thiazole or benzothiazole and other biologically active heterocyclic compounds. These compounds were synthesized via multi-step experiment and successfully confirmed through different characterization techniques for their ability to inhibit cAMP formation in A(2A)AR overexpressing cells. The thiazole derivative of istradefylline (Compound I-1-11, I-1-12) exhibited significant activity (IC50 = 16.74 +/- 4.11 mu M, 10.36 +/- 3.09 mu M), as compared to istradefylline (IC50 = 5.05 +/- 1.32 mu M). In addition, the molecular docking of benzothiazole derivatives I-1-11 and thiazole derivatives I-1-12 with higher inhibition rate were carried out and compared with istradefylline. The molecular docking results showed that I-1-11 and I-1-12 anchored in the same site as that of XAC (3REY) with predicted affinity binding energy -6.63 kcal/mol and - 6.75 kcal/mol, respectively. Validation through dynamics simulation also showed stable interactions, with fluctuations <3 angstrom and MM/GBSA energy <-20 kcal/mol. Hence, this study could provide a basis for the rational design of adenosine A(2A) receptor antagonists with better potency.

Concise Syntheses Of Trifluoromethylated Cyclic And Acyclic Analogues Of Cadpr

Design and Synthesis of Cadpr Analogues with Simplified Ribose and Nucleobase

Synthesis And Calcium Mobilization Activity Of Cadpr Analogues Which Integrate Nucleobase, Northern And Southern Ribose Modifications

Concise Synthesis of Novel Acyclic Analogues of Cadpr with an Ether Chain As the Northern Moiety

Trifluoromethylated Cyclic-Adp-ribose Mimic: Synthesis of 8-Trifluoromethyl-n(1)-[(5''-o-phosphorylethoxy)methyl]-5'-o-phosphorylinosine-5',5''-cyclic Pyrophosphate (8-Cf(3)-cidpre) and Its Calcium Release Activity in T Cells.

Synthesis And Biological Evaluation Of Novel Membrane-Permeant Cyclic Adp-Ribose Mimics: N-1-[(5 ''-O-Phosphorylethoxy)Methyl]-5 '-O-Phosphorylinosine 5 ',5 ''-Cyclicpyrophosphate (Cidpre) And 8-Substituted Derivatives

Studies on Cyclic ADP-ribose (cADPR) Analogues: Synthesis and Calcium Release Activity

The Effect of gem-Difluorination on the Conformation and Properties of a Model Macrocyclic System

Cyclic 3-deaza-adenosine diphosphoribose: a potent and stable analog of cyclic ADP-ribose.

Novel Nucleobase-Simplified Cyclic ADP-ribose Analogue: A Concise Synthesis and Ca(2+)-mobilizing Activity in T-lymphocytes.

Preparation of Cyclic ADP-ribose Antagonists and Caged Cyclic ADP-ribose.

A Novel Membrane-Permeant Cadpr Antagonist Modified in the Pyrophosphate Bridge.

Design, Synthesis, and Structure-Activity Relationship of New Pyrimidinamine Derivatives Containing an Aryloxy Pyridine Moiety.

Synthesis of novel ADPR analogues: substitution of pyrophosphate linkage by dipeptide

Optimization of Microwave-Assisted Synthesis of N1-ethoxymethyl-substituted Cyclic Inosine Diphosphoribose and Its Analogues

Design and Synthesis of Five‐membered Heterocyclic Derivatives of Istradefylline with Comparable Pharmacological Activity

Syntheses and Calcium-Mobilizing Evaluations of N1-glycosyl-substituted Stable Mimics of Cyclic ADP-ribose.

Chemical Synthesis,Characterization and Biological Properties of a Novel Cyclic ADP-Ribose Analogue

New Potential Calcium Channel Modulators: Design and Synthesis of Compounds Containing Two Pyridine, Pyrimidine, Pyridone, Quinoline and Acridine Units under Microwave Irradiation.

Convenient and efficient access to tri- and tetra-substituted 4-fluoropyridines via a [3+2]/[2+1] cyclization reaction